News
FDA experts endorse Moderna's mRNA seasonal flu shot
A unanimous endorsement from FDA advisors brings Moderna's RNA-based seasonal influenza vaccine a step closer to US approval.
News
MSD takes on Pfizer's Prevnar with new Capvaxive approval
MSD has claimed new territory for pneumococcal vaccines after getting FDA approval for use of Capvaxive in vulnerable children aged two to 17.
News
FDA approves first generic of Roche's flu drug Xofluza
The first generic of Roche's drug for influenza, Xofluza, has been approved by the FDA and should be available in time for this year's flu season.
News
UK will be first market for Sanofi's subcutaneous Sarclisa
Sanofi's on-body injector version of multiple myeloma therapy Sarclisa has been cleared in the UK, which will be the first market for the product.
News
GSK claims FDA okay for first oral carbapenem antibiotic
GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
